Neurological morbidity after fetal XXXX .

@entity1 @entity712 @entity2806 @entity548 @entity75 @entity4 @entity591 @entity4710 @entity943
BACKGROUND: Fetal @entity591 is a well-documented entity which, in the absence of pharmacological intervention, may lead to @entity712 , fetal @entity4 and eventually fetal demise. The success rate of the implemented treatment is generally measured by survival and achievement of control of the @entity943 . We report on the occurrence of associated @entity75 in three @entity1 with fetal @entity591 . METHODS: We describe three @entity1 with a history of fetal @entity4710 who developed cerebral complications in utero. RESULTS: Two @entity1 had cerebral @entity2806 and one had @entity548 present at birth. They had developed severe @entity712 and fetal @entity4 secondary to fetal @entity591 , and there were no other obvious causes for the cerebral pathology. Two of these @entity1 were referred to us antenatally. Therapy was instituted and resulted in control of the @entity591 and resolution of @entity4 . The third @entity1 was referred to our clinic shortly after birth because of severe circulatory problems secondary to fetal @entity591 . CONCLUSION: From these observations, we believe that a fetus with @entity591 and subsequent @entity4 is at increased risk for the development of cerebral complications, due to the circulatory disturbances and sudden changes in heart rate which may lead to fluctuations in cerebral perfusion. This would imply that it is of the utmost importance to aim at immediate and complete control of the heart rate in the treatment of fetal @entity591 .
